- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Targeting triple negative breast cancer stem cells using nanocarriers ; volume:19 ; number:1 ; day:7 ; month:3 ; year:2024 ; pages:1-29 ; date:12.2024
Discover nano ; 19, Heft 1 (7.3.2024), 1-29, 12.2024
- Urheber
-
Dasari, Nagasen
Guntuku, Girija Sankar
Pindiprolu, Sai Kiran S. S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s11671-024-03985-y
- URN
-
urn:nbn:de:101:1-2405102108032.705134708368
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dasari, Nagasen
- Guntuku, Girija Sankar
- Pindiprolu, Sai Kiran S. S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The role of KDM4 inhibition in targeting cancer stem cells from triple-negative breast cancer
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
Magnetic-guided nanocarriers for ionizing/non-ionizing radiation synergistic treatment against triple-negative breast cancer
Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer
Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
Targeting a cell state common to triple‐negative breast cancers
Riboflavin functionalized nanocarriers for active targeting of cancer cells
Tailored Multivalent Targeting of Siglecs with Photosensitizing Liposome Nanocarriers
Tailored Multivalent Targeting of Siglecs with Photosensitizing Liposome Nanocarriers
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Therapeutic Nanocarriers Inhibit Chemotherapy‐Induced Breast Cancer Metastasis
Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells
The role of KDM4 inhibition in targeting cancer stem cells from triple-negative breast cancer
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
Magnetic-guided nanocarriers for ionizing/non-ionizing radiation synergistic treatment against triple-negative breast cancer
Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer
Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
Targeting a cell state common to triple‐negative breast cancers
Riboflavin functionalized nanocarriers for active targeting of cancer cells
Tailored Multivalent Targeting of Siglecs with Photosensitizing Liposome Nanocarriers
Tailored Multivalent Targeting of Siglecs with Photosensitizing Liposome Nanocarriers
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Therapeutic Nanocarriers Inhibit Chemotherapy‐Induced Breast Cancer Metastasis
Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells
The role of KDM4 inhibition in targeting cancer stem cells from triple-negative breast cancer
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
Magnetic-guided nanocarriers for ionizing/non-ionizing radiation synergistic treatment against triple-negative breast cancer
Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer
Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
Targeting a cell state common to triple‐negative breast cancers
Riboflavin functionalized nanocarriers for active targeting of cancer cells
Tailored Multivalent Targeting of Siglecs with Photosensitizing Liposome Nanocarriers
Tailored Multivalent Targeting of Siglecs with Photosensitizing Liposome Nanocarriers
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Therapeutic Nanocarriers Inhibit Chemotherapy‐Induced Breast Cancer Metastasis